|4Mar 5, 7:14 PM ET

Buckley Stephen Jr. 4

4 · ENANTA PHARMACEUTICALS INC · Filed Mar 5, 2018

Insider Transaction Report

Form 4
Period: 2018-02-28
Transactions
  • Award

    Stock Option (right to buy)

    2018-02-28+7,5007,500 total
    Exercise: $78.62Exp: 2028-02-28Common Stock (7,500 underlying)
Footnotes (1)
  • [F1]Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 28, 2018), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2019 annual meeting of stockholders.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT